Solid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular Dystrophy
February 21, 2018 at 09:18 AM EST
The young biotech firm Solid Biosciences Inc (NASDAQ: SLDB)secured two Buy ratings Tuesday and another Wednesday. The ...